Skip to main content
. 2022 Jul 16;15:69–85. doi: 10.2147/TACG.S365613

Figure 2.

Figure 2

(A) ROC curve for CircANXA2, Circ0075001, and CircFBXW7 to discriminate AML from control. (B) Relation between high and low CircANAX2 expression with FAB classification in AML patients. (C) Relation between high and low CircANAX2 expression with Cytogenetic criteria in AML patients. (D) Relation between high and low CircANAX2 expression with Overall survival in AML patients. (E) Relation between high and low Circ0075001expression with FAB classification in AML. (F) Relation between high and low Circ0075001 expression with Cytogenetic criteria in AML. *Statistically significant at p ≤ 0.05.